Patents by Inventor David Tatum

David Tatum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951188
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: April 9, 2024
    Assignee: LUMIPHORE, INC.
    Inventors: David Tatum, Jide Xu, Darren Magda, Nathaniel Butlin
  • Publication number: 20240067650
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Application
    Filed: March 10, 2023
    Publication date: February 29, 2024
    Inventors: David Tatum, Jide Xu, Darren Magda, Nathaniel Butlin
  • Publication number: 20240059668
    Abstract: There is a provided metal ion chelating agents capable of stably binding soft Lewis acid metal ions, metal ion chelates based on these chelating agents, and methods of using the compounds of the invention in diagnostic and therapeutics methods. Also provided are methods of sequestering soft Lewis acid metal ions. Exemplary soft Lewis acid metal ions are radionuclides.
    Type: Application
    Filed: October 21, 2021
    Publication date: February 22, 2024
    Inventors: Darren MAGDA, David TATUM
  • Patent number: 11603371
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: March 14, 2023
    Assignee: LUMIPHORE, INC.
    Inventors: David Tatum, Jide Xu, Darren Magda, Nathaniel Butlin
  • Publication number: 20210290787
    Abstract: The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications. In various embodiments, the invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA express-ing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: June 19, 2019
    Publication date: September 23, 2021
    Inventors: Darren MAGDA, David TATUM, Nathaniel G. BUTLIN
  • Publication number: 20200405887
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Application
    Filed: March 7, 2019
    Publication date: December 31, 2020
    Inventors: David TATUM, Jide XU, Darren MAGDA, Nathaniel BUTLIN
  • Publication number: 20200062757
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Application
    Filed: March 25, 2019
    Publication date: February 27, 2020
    Inventors: David Tatum, Jide Xu, Darren Magda, Nathaniel Butlin
  • Patent number: 10239878
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: March 26, 2019
    Assignee: LUMIPHORE, INC.
    Inventors: David Tatum, Jide Xu, Darren Magda, Nathaniel Butlin
  • Publication number: 20180194766
    Abstract: The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 12, 2018
    Inventors: David Tatum, Jide Xu, Darren Magda, Nathaniel Butlin